Navigation Links
Spherix to Effect Reverse Stock Split
Date:4/19/2011

erse split can be obtained by contacting American Stock Transfer & Trust Company's shareholder services department at 877 248-6417 or 718 921-8317.

The purpose of the reverse stock split is to raise the per share trading price of the Company's common stock to better enable the Company to maintain the listing of its common stock on The NASDAQ Capital Market ("NASDAQ"). As previously announced, in order to maintain the Company's listing on NASDAQ, on or before May 23, 2011, the Company's common stock must have a closing bid price of $1.00 or more for a minimum of 10 prior consecutive trading days. If the Company is unable to meet this requirement, the NASDAQ Listing Qualifications Panel will issue a final determination to delist and suspend trading of the Company's common stock. There can be no assurance that the reverse stock split will have the desired effect of raising the closing bid price of the Company's common stock prior to May 23, 2011, to meet this requirement.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research. The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is dedicated to development of D-tagatose and recently completed a Phase 3 clinical trial to study the use of D-tagatose as a treatment for Type 2 diabetes. Biospherics is actively seeking a pharma partner to continue the diabetes development while exploring D-tagatose as a potential treatment for high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke. Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharma
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spherix Announces 2010 Financial Results
2. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
3. Spherix to Present at the 13th Annual BIO CEO & Investor Conference
4. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
5. Spherix to Present at Two Upcoming Prominent Finance Conferences
6. Spherix Phase 2 Trial with D-tagatose Determines Minimum Dose for HbA1c and Triglycerides
7. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
8. Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
9. Spherix Announces Closing of Institutional Investors Purchase of $5.25 Million of Convertible Preferred Stock and Warrants
10. Spherix Announces Statistically Significant Results in Phase 3 Study With D-tagatose in Type 2 Diabetes
11. Spherix Announces Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014   Sequenom, Inc. ... company that provides innovative genetic analysis solutions, and ... esoteric laboratory services in the United States ... prenatal testing patents and applications. "We have ... and patient care, and we welcome the opportunity to ...
(Date:7/29/2014)... particle be separated from its properties? On July 29, ... results of the first Cheshire Cat experiment, separating a ... in Orange, CA, and Vienna University of Technology. , ... grin," thought Alice in Wonderland, "but a grin without ... saw in my life!" Alice,s surprise stems from her ...
(Date:7/29/2014)... has created a new way of manufacturing microstructured ... made by self-assembly of carbon nanotubes, could exhibit ... mechanical stiffness and strength, or the ability to ... have demonstrated that mechanical forces can be used ... and that we can independently control the ...
(Date:7/29/2014)... YORK , July 29, 2014  Pomerantz LLP ... Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL).  Such ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... of its officers and/or directors have violated Sections 10(b) ... On July 29, 2014, Impax Laboratories, ...
Breaking Biology Technology:Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4A new way to make microstructured surfaces 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2
... 14, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... DIEGO, Sept. 14 Stemedica Cell Technologies, Inc., a ... announced today that it has completed its proprietary master ... cell bank was manufactured in accordance with FDA Good ... all the necessary safety testing required by the FDA ...
... Regenicin™, Inc. (OTC Bulletin Board: ... today that John J. Weber, the former highest ranking ... ("Fujifilm USA"), has agreed to join the company as ... Chief Financial Officer.  Weber brings over 20 years of ...
Cached Biology Technology:NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 2NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 3NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 4NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 5NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 6NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership 7Stemedica Announces Completion of Clinical Stem Cell Master Bank 2Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO 2
(Date:7/30/2014)... develop into a multitude of cells types. Researchers would like ... types of mature cells that make up the organs and ... to be long chains of sugars that dangle from proteins ... University of California, San Diego, has created synthetic molecules that ... more easily manipulated to direct the process, they report in ...
(Date:7/30/2014)... the journal Scientific Reports , published by ... found that while global temperature is indeed increasing, so ... while each year,s average hottest and coldest temperatures will ... within a wider range of potential high and low ... that even as overall temperatures rise, we may still ...
(Date:7/29/2014)... science, researchers sometimes need to get back to ... that to study the impacts of the bumphead ... ecosystems at two remote locations in the central ... and computer simulation, McCauley, an assistant professor in ... and his colleagues sought to understand whether the ...
Breaking Biology News(10 mins):Big data confirms climate extremes are here to stay 2Underwater elephants 2Underwater elephants 3
... Dr. Gregory King, professor and chair of the Department ... the recipient of the 2009 Craniofacial Biology Research Award, ... Research (IADR) at its 87th General Session & Exhibition ... King began his undergraduate studies in Biology at Brown ...
... sinks have on rising carbon emissions is gradually weakening, ... grasslands and oceans are absorbing carbon dioxide (CO 2 ... are not keeping pace with rapidly rising emissions," says ... Dr Mike Raupach. "While these natural CO 2 ...
... in Newark and the surrounding area, NJIT has received a ... This grant renews the Foundation,s valuable support ... about nutrition, physical fitness and healthy lifestyles. At NJIT, the ... Education in Greater Newark, a partnership of NJIT, Rutgers University ...
Cached Biology News:Carbon sinks losing the battle with rising emissions 2
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...
Anti-Mouse D011.10 TCR, Biotin (Clone KJ1-26) (mouse IgG2a)...
Reacts with methylated DNA from plants and vertebrates...
Biology Products: